Laurus Labs Limited vs Morepen Laboratories Limited

A side-by-side comparison of Laurus Labs Limited (LAURUSLABS) and Morepen Laboratories Limited (MOREPENLAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Laurus Labs Limited leads LAURUSLABS vs MOREPENLAB on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability40
  • Growth02
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

MOREPENLAB takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

125.08
P/E ratio
57.44
19.74
P/B ratio
5.06
0.10%
Dividend yield
0.17%
₹16.47
EPS
₹2.15

Profitability

LAURUSLABS takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

16.77%
Return on equity
0.00%
17.58%
Return on capital
9.32%
26.09%
EBITDA margin
6.96%
13.07%
Net margin
5.25%

Growth

MOREPENLAB takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

4.09%
Revenue CAGR (3Y)
8.39%
3.91%
Profit CAGR (3Y)
34.49%

Size & financial health

LAURUSLABS takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.11L Cr
Market cap
₹6,773 Cr
₹6,813 Cr
Revenue
₹1,806 Cr
₹890 Cr
Net profit
₹95 Cr
0.45
Debt / equity
0.17
Laurus Labs Limited
  • + []
  • − ["Stock is trading at 20.99 times its book value", "The company has delivered a poor sales growth of 7.2% over past five years.", "The company has delivered a poor profit growth of -2.0% over past five years."]
Morepen Laboratories Limited
  • + []
  • − ["Stock is trading at 5.43 times its book value", "The company has delivered a poor sales growth of 8.7% over past five years.", "The company has delivered a poor profit growth of -0.4% over past five years."]
Laurus Labs Limited full analysis Morepen Laboratories Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.